Inhibition of Caco-2 cell proliferation by (n-3) fatty acids: Possible mediation by increased secretion of insulin-like growth factor binding protein-6
Ej. Kim et al., Inhibition of Caco-2 cell proliferation by (n-3) fatty acids: Possible mediation by increased secretion of insulin-like growth factor binding protein-6, NUTR RES, 20(10), 2000, pp. 1409-1421
The present study was performed to examine the effect of various polyunsatu
rated fatty acids (PUFAs) on the proliferation of the human colon adenocarc
inoma cell line, Caco-2 cells. The ability of individual PUFAs to stimulate
cell proliferation was examined by culturing cells in serum-free medium. E
icosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) inhibited cell pr
oliferation, and therefore, cells cultured with 100 mu M EPA or DHA reached
much lower final densities compared to cells cultured with 2 mu M linoleic
acid (control) or 100 mu M linoleic acid (LA). Insulin-like growth factors
(IGFs) are autocrine and paracrine growth promoters of a variety of cells,
and a family of IGF binding proteins (IGFBPs) modulates the biological act
ions of IGF-I and IGF-II. Since IGF-II has been shown to be an autocrine re
gulator of Caco-2 cells, we investigated the effects of these PUFAs on IGF-
II and IGFBP secretion in association with Caco-2 cell proliferation. Immun
oblot analysis of serum-free conditioned medium using a monoclonal anti-IGF
-II antibody showed that concentrations of both mature 7,500 M-r and higher
M-r forms of pro IGF-II were lower in conditioned medium by cells treated
with EPA or DHA compared with LA. Ligand blot analysis revealed that the se
cretion of IGFBP-6 was significantly higher in cells treated with 100 mu M
EPA or DHA compared to LA. Northern blot analysis demonstrated that the ste
ady state levels of IGFBP-6 mRNA were higher in cells cultured with EPA or
DHA compared to the controls. Exogenously added IGFBP-6 inhibited Caco-2 ce
ll proliferation. We propose that low IGF-II/IGFBP-6 ratios may have result
ed in less free IGF-II and, consequently, the slower proliferation of Caco-
2 cells treated with EPA or DHA. (C) 2000 Elsevier Science Inc.